Table 3.
Antitoxin Treatment in Human Inhalation Anthrax
Case | Age | Gender | Exposure | Clinical Presentation | Antimicrobial Initiation Post Symptom Onset (Days) | Antimicrobial Treatment | Additional Supportive Care | Anthrasil Administration Post Symptom Onset (Days) | Outcome |
---|---|---|---|---|---|---|---|---|---|
44, 47 | 44 | M | Animal hide drums | Dyspnea, cough, syncope, chest pain, bilateral pleural effusions, mediastinal fluid, progressive respiratory failure, elevated liver enzymes, elevated creatinine | 2–3 | Ceftriaxone, azithromycin, moxifloxacin, clindamycin, piperacillin/tazobactam | Mechanical ventilation, pleural fluid drainage, vasopressors | 9 | Lived |
45, 46 | 61 | M | Unknown, presumed environmental | Fever, productive cough, exertional dyspnea, progressive respiratory failure, elevated creatinine | 2 | Ceftriaxone, azithromycin, ciprofloxacin, meropenem, vancomycin, rifampin, clindamycin | Mechanical ventilation, pleural fluid drainage | 7 | Lived |
42, 43 | 34 | M | Animal hide drums | Fever, night sweats, rigors, rapid respiratory failure, pleural effusions, widened mediastinum, multi-organ failure | 2 | Amoxicillin, clarithromycin, piperacillin/tazobactam, rifampicin, ciprofloxacin, clindamycin | Multi-organ support: mechanical ventilation, pleural fluid drainage, vasopressors, steroids | 8 | Died |